Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To compare the effect of the rapid-acting insulin analogues (RAIAs) NovoRapid (aspart) and Prandilin (lispro) on glycemic variations by Continuous glucose monitoring system (CGMS) in continuous subcutaneous insulin infusion (CSII) with metformin intensive therapy in newly diagnosed type 2 diabetes mellitus (T2DM).
Epistemonikos ID: 71118c6569059014f7ef19a33ef24f9431419fc7
First added on: May 21, 2024